Calli Lear
Impact in
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
- Emergency Medical Services top 5%
- Disaster Response and Management
Papers in ⓘ
-
- Viral Infections and Outbreaks Research 5
- SARS-CoV-2 and COVID-19 Research 2
- Viral Infections and Vectors 2
- Viral gastroenteritis research and epidemiology 2
-
- Glutathione Transferases and Polymorphisms 1
- Co-authors
- Gene G. Olinger (6 shared papers)Corinne Scully (3 shared papers)Lisa E. Hensley (3 shared papers)Lisa Evans DeWald (1 shared paper)Joseph Lehár (1 shared paper)Charles J. Shoemaker (1 shared paper)Benjamin G. Hoffstrom (1 shared paper)Kathryn L. Schornberg (1 shared paper)
- Journals
- The Journal of Infectious Diseases (1 paper)Science Translational Medicine (1 paper)Antiviral Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesAustraliaRussia
In The Last Decade
Calli Lear
6 papers receiving 666 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 491
- Emergency Medical Services 70
- Biotechnology 72
- Epidemiology 213
- Immunology 92
Countries citing papers authored by Calli Lear
This map shows the geographic impact of Calli Lear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calli Lear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calli Lear more than expected).
Fields of papers citing papers by Calli Lear
This network shows the impact of papers produced by Calli Lear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calli Lear. The network helps show where Calli Lear may publish in the future.
Co-authors
The 25 scholars most cited alongside Calli Lear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 258 | |
| 2 | 2013 | 249 | |
| 3 | 2010 | 78 | |
| 4 | 2010 | 50 | |
| 5 | FGI-104: a broad-spectrum small molecule inhibitor of viral infection. | 2009 | 40 |
| 6 | 2009 | 23 |
About Calli Lear
Calli Lear is a scholar working on Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 6 papers that have together received 698 indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Viral Infections and Vectors (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Ethics and Legal Issues in Pediatric Healthcare (1 paper), Glutathione Transferases and Polymorphisms (1 paper), COVID-19 Impact on Reproduction (1 paper) and Transgenic Plants and Applications (1 paper). The work is most often cited by research in Infectious Diseases (491 citations), Emergency Medical Services (70 citations), Biotechnology (72 citations), Epidemiology (213 citations) and Immunology (92 citations). Calli Lear has collaborated with scholars based in United States, Australia and Russia. Frequent co-authors include Gene G. Olinger, Corinne Scully, Lisa E. Hensley, Lisa Evans DeWald, Joseph Lehár, Charles J. Shoemaker, Benjamin G. Hoffstrom, Kathryn L. Schornberg, Jennifer M. Brannan and Judith M. White. Their work appears in journals such as The Journal of Infectious Diseases, Science Translational Medicine, Antiviral Research, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.